Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Humanized Monoclonal Antibody Blocking Carbonic Anhydrase 12 Enzymatic Activity Leads to Reduced Tumor Growth In Vitro.

Uda NR, Stenner F, Seibert V, Herzig P, Markuly N, VAN Dijk M, Zippelius A, Renner C.

Anticancer Res. 2019 Aug;39(8):4117-4128. doi: 10.21873/anticanres.13570.

PMID:
31366496
2.

A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung Cancer.

Trefny MP, Rothschild SI, Uhlenbrock F, Rieder D, Kasenda B, Stanczak MA, Berner F, Kashyap AS, Kaiser M, Herzig P, Poechtrager S, Thommen DS, Geier F, Savic S, Jermann P, Alborelli I, Schaub S, Stenner F, Früh M, Trajanoski Z, Flatz L, Mertz KD, Zippelius A, Läubli H.

Clin Cancer Res. 2019 May 15;25(10):3026-3034. doi: 10.1158/1078-0432.CCR-18-3041. Epub 2019 Feb 14.

PMID:
30765392
3.

[Treatment of Advanced Prostate Carcinoma - an Interdisciplinary Recommendation].

Omlin A, Spahn M, Beyer J, Eberli D, Gillessen S, Jochum W, Kueng M, Nitzsche E, Rentsch CA, Roggero E, Schmid HP, Stenner F, Templeton AJ, Wild D, Wyler S, Zwahlen D, Cathomas R.

Praxis (Bern 1994). 2018 Sep;107(19):1043-1051. doi: 10.1024/1661-8157/a003054. Review. German. No abstract available.

PMID:
30227804
4.

Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells.

Stanczak MA, Siddiqui SS, Trefny MP, Thommen DS, Boligan KF, von Gunten S, Tzankov A, Tietze L, Lardinois D, Heinzelmann-Schwarz V, von Bergwelt-Baildon M, Zhang W, Lenz HJ, Han Y, Amos CI, Syedbasha M, Egli A, Stenner F, Speiser DE, Varki A, Zippelius A, Läubli H.

J Clin Invest. 2018 Nov 1;128(11):4912-4923. doi: 10.1172/JCI120612. Epub 2018 Sep 24.

5.

Diagnosis and treatment of follicular lymphoma: an update.

Bargetzi M, Baumann R, Cogliatti S, Dietrich PY, Duchosal M, Goede J, Hitz F, Konermann C, Lohri A, Mey U, Novak U, Papachristofilou A, Stenner F, Taverna C, Zander T, Renner C.

Swiss Med Wkly. 2018 Jul 24;148:w14635. doi: 10.4414/smw.2018.14635. eCollection 2018. Review.

6.

Cancer Immunotherapy and the Immune Response in Follicular Lymphoma.

Stenner F, Renner C.

Front Oncol. 2018 Jun 19;8:219. doi: 10.3389/fonc.2018.00219. eCollection 2018. Review.

7.

Cancer Immunotherapy and the Immune Response in Hodgkin Lymphoma.

Renner C, Stenner F.

Front Oncol. 2018 Jun 4;8:193. doi: 10.3389/fonc.2018.00193. eCollection 2018. Review.

8.

Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events.

Läubli H, Balmelli C, Kaufmann L, Stanczak M, Syedbasha M, Vogt D, Hertig A, Müller B, Gautschi O, Stenner F, Zippelius A, Egli A, Rothschild SI.

J Immunother Cancer. 2018 May 22;6(1):40. doi: 10.1186/s40425-018-0353-7.

9.

Pattern of Care Study in Metastatic Renal-Cell Carcinoma in the Preimmunotherapy Era in Switzerland.

Sandmeier N, Rothschild SI, Rothermundt C, Cathomas R, Schardt J, Berthold D, von Burg P, Müller B, Beyer J, Vogt DR, Stenner F.

Clin Genitourin Cancer. 2018 Aug;16(4):e711-e718. doi: 10.1016/j.clgc.2018.01.002. Epub 2018 Feb 2.

PMID:
29503245
10.

Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program.

Balmelli C, Railic N, Siano M, Feuerlein K, Cathomas R, Cristina V, Güthner C, Zimmermann S, Weidner S, Pless M, Stenner F, Rothschild SI.

J Cancer. 2018 Jan 1;9(2):250-255. doi: 10.7150/jca.22318. eCollection 2018.

11.

Quality of Life in Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer Using Cabazitaxel or Other Therapies After Previous Docetaxel Chemotherapy: Swiss Observational Treatment Registry.

Stenner F, Rothschild SI, Betticher D, Caspar C, Morant R, Popescu R, Rauch D, Huber U, Zenhäusern R, Rentsch C, Cathomas R.

Clin Genitourin Cancer. 2017 Aug 24. pii: S1558-7673(17)30244-6. doi: 10.1016/j.clgc.2017.08.003. [Epub ahead of print]

PMID:
28958629
12.

RNF41 interacts with the VPS52 subunit of the GARP and EARP complexes.

Masschaele D, De Ceuninck L, Wauman J, Defever D, Stenner F, Lievens S, Peelman F, Tavernier J.

PLoS One. 2017 May 22;12(5):e0178132. doi: 10.1371/journal.pone.0178132. eCollection 2017.

13.

Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse.

Gössi F, Spahn M, Zweifel M, Panagiotis S, Mischo A, Stenner F, Hess U, Berthold D, Bargetzi M, Schardt J, Pabst T.

Bone Marrow Transplant. 2017 Feb;52(2):334-336. doi: 10.1038/bmt.2016.285. Epub 2016 Nov 28. No abstract available.

PMID:
27892951
14.

Enzalutamide in Patients With Castration-Resistant Prostate Cancer Progressing After Docetaxel: Retrospective Analysis of the Swiss Enzalutamide Named Patient Program.

Papazoglou D, Wannesson L, Berthold D, Cathomas R, Gillessen S, Rothermundt C, Hasler L, Winterhalder R, Barth A, Mingrone W, Nussbaum CU, von Rohr L, von Burg P, Schmid M, Richner J, Baumann S, Kühne R, Stenner F, Rothschild SI.

Clin Genitourin Cancer. 2017 Jun;15(3):e315-e323. doi: 10.1016/j.clgc.2016.06.011. Epub 2016 Jun 23.

PMID:
27450512
15.

Safety and efficacy of cryopreserved autologous platelet concentrates in HLA-alloimmunized patients with hematologic malignancies.

Gerber B, Alberio L, Rochat S, Stenner F, Manz MG, Buser A, Schanz U, Stussi G.

Transfusion. 2016 Oct;56(10):2426-2437. doi: 10.1111/trf.13690. Epub 2016 Jun 24.

PMID:
27339466
16.

Treatment, Outcome and Prognostic Factors in Renal Cell Carcinoma - A Single Center Study (2000-2010).

Achermann C, Stenner F, Rothschild SI.

J Cancer. 2016 May 8;7(8):921-7. doi: 10.7150/jca.15228. eCollection 2016.

17.

Three Genes to Predict Response to Chemotherapy for Bladder Cancer: Individualised Cancer Care at the Doorstep.

Rentsch CA, Stenner F, Ruiz C, Bubendorf L.

Eur Urol. 2015 Dec;68(6):968-9. doi: 10.1016/j.eururo.2015.07.050. Epub 2015 Aug 13. No abstract available.

PMID:
26278806
18.

HLA-B27-Homodimer-Specific Antibody Modulates the Expansion of Pro-Inflammatory T-Cells in HLA-B27 Transgenic Rats.

Marroquin Belaunzaran O, Kleber S, Schauer S, Hausmann M, Nicholls F, Van den Broek M, Payeli S, Ciurea A, Milling S, Stenner F, Shaw J, Kollnberger S, Bowness P, Petrausch U, Renner C.

PLoS One. 2015 Jun 30;10(6):e0130811. doi: 10.1371/journal.pone.0130811. eCollection 2015.

19.

Successful Salvage Chemotherapy with FOLFIRINOX for Recurrent Mixed Acinar Cell Carcinoma and Ductal Adenocarcinoma of the Pancreas in an Adolescent Patient.

Pfrommer S, Weber A, Dutkowski P, Schäfer NG, Müllhaupt B, Bourquin JP, Breitenstein S, Pestalozzi BC, Stenner F, Renner C, D'Addario G, Graf HJ, Knuth A, Clavien PA, Samaras P.

Case Rep Oncol. 2013 Sep 28;6(3):497-503. doi: 10.1159/000355320. eCollection 2013.

20.

Antigen-specific in vitro expansion of functional redirected NY-ESO-1-specific human CD8+ T-cells in a cell-free system.

Jakka G, Schuberth PC, Thiel M, Held G, Stenner F, Van Den Broek M, Renner C, Mischo A, Petrausch U.

Anticancer Res. 2013 Oct;33(10):4189-201.

PMID:
24122982
21.

RP1 is a phosphorylation target of CK2 and is involved in cell adhesion.

Stenner F, Liewen H, Göttig S, Henschler R, Markuly N, Kleber S, Faust M, Mischo A, Bauer S, Zweifel M, Knuth A, Renner C, Wadle A.

PLoS One. 2013 Jul 3;8(7):e67595. doi: 10.1371/journal.pone.0067595. Print 2013.

22.

Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08).

Templeton AJ, Dutoit V, Cathomas R, Rothermundt C, Bärtschi D, Dröge C, Gautschi O, Borner M, Fechter E, Stenner F, Winterhalder R, Müller B, Schiess R, Wild PJ, Rüschoff JH, Thalmann G, Dietrich PY, Aebersold R, Klingbiel D, Gillessen S; Swiss Group for Clinical Cancer Research (SAKK).

Eur Urol. 2013 Jul;64(1):150-8. doi: 10.1016/j.eururo.2013.03.040. Epub 2013 Apr 6.

PMID:
23582881
23.

[New drug treatment possibilities in castration resistant prostate carcinoma].

Meisel A, Stenner F.

Praxis (Bern 1994). 2012 Sep 5;101(18):1143-9; quiz 1150-1. doi: 10.1024/1661-8157/a001052. Review. German. No abstract available.

PMID:
22945814
24.

A pooled analysis of sequential therapies with sorafenib and sunitinib in metastatic renal cell carcinoma.

Stenner F, Chastonay R, Liewen H, Haile SR, Cathomas R, Rothermundt C, Siciliano RD, Stoll S, Knuth A, Buchler T, Porta C, Renner C, Samaras P.

Oncology. 2012;82(6):333-40. doi: 10.1159/000338001. Epub 2012 Jun 2.

25.

[After care in Hodgkin lymphoma].

Petrausch U, Samaras P, Mischo A, Stenner F, Tinguely M, Schäfer N, Studer G, Renner C.

Praxis (Bern 1994). 2011 Dec 14;100(25):1515-20; quiz 1521-2. doi: 10.1024/1661-8157/a000744. German. No abstract available.

PMID:
22161876
26.

Autologous stem cell transplantation: leukapheresis product has anti-angiogenic effects in vivo correlating with neutrophil-derived VEGFR1.

Luethy A, Stenner F, Lohri C, Muller C, Samaras P, Steiner R, Van Den Broek M, Mischo A, Renner C, Knuth A, Ruegg C, Wenger RH, Zweifel M.

Anticancer Res. 2011 Oct;31(10):3115-24.

PMID:
21965716
27.

Multicentric Castleman's disease as a cause for unclear febrile episodes in a 55-year-old HIV-infected man.

Lederer H, Achermann Y, Tinguely M, Stenner F, Fehr J.

Infection. 2012 Apr;40(2):203-5. doi: 10.1007/s15010-011-0174-9. Epub 2011 Aug 12.

28.

Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound.

Goetti R, Reiner CS, Knuth A, Klotz E, Stenner F, Samaras P, Alkadhi H.

Invest Radiol. 2012 Jan;47(1):18-24. doi: 10.1097/RLI.0b013e318229ff0d.

PMID:
21788906
29.

The androgen-regulated Calcium-Activated Nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in vitro.

Gerhardt J, Steinbrech C, Büchi O, Behnke S, Bohnert A, Fritzsche F, Liewen H, Stenner F, Wild P, Hermanns T, Müntener M, Dietel M, Jung K, Stephan C, Kristiansen G.

Am J Pathol. 2011 Apr;178(4):1847-60. doi: 10.1016/j.ajpath.2010.12.046.

30.

Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort.

Cathomas R, Helbling D, Stenner F, Rothermundt C, Rentsch C, Shahin O, Seifert HH, Zaugg K, Lorch A, Mayer F, Beyer J, De Santis M, Gillessen S.

Swiss Med Wkly. 2010 Jun 26;140(25-26):356-69. doi: smw-12993. Review.

31.

Quantitative computed tomography liver perfusion imaging using dynamic spiral scanning with variable pitch: feasibility and initial results in patients with cancer metastases.

Goetti R, Leschka S, Desbiolles L, Klotz E, Samaras P, von Boehmer L, Stenner F, Reiner C, Stolzmann P, Scheffel H, Knuth A, Marincek B, Alkadhi H.

Invest Radiol. 2010 Jul;45(7):419-26. doi: 10.1097/RLI.0b013e3181e1937b.

PMID:
20498611
32.

A novel syntaxin 6-interacting protein, SHIP164, regulates syntaxin 6-dependent sorting from early endosomes.

Otto GP, Razi M, Morvan J, Stenner F, Tooze SA.

Traffic. 2010 May;11(5):688-705. doi: 10.1111/j.1600-0854.2010.01049.x.

33.

Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas.

Riener MO, Stenner F, Liewen H, Hellerbrand C, Bahra M, Kristiansen G.

Hepatology. 2009 Jul;50(1):326. doi: 10.1002/hep.23053. No abstract available.

PMID:
19496179
34.

Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNg.

Bauer S, Oosterwijk-Wakka JC, Adrian N, Oosterwijk E, Fischer E, Wüest T, Stenner F, Perani A, Cohen L, Knuth A, Divgi C, Jäger D, Scott AM, Ritter G, Old LJ, Renner C.

Int J Cancer. 2009 Jul 1;125(1):115-23. doi: 10.1002/ijc.24359.

35.

Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas.

Riener MO, Stenner F, Liewen H, Soll C, Breitenstein S, Pestalozzi BC, Samaras P, Probst-Hensch N, Hellerbrand C, Müllhaupt B, Clavien PA, Bahra M, Neuhaus P, Wild P, Fritzsche F, Moch H, Jochum W, Kristiansen G.

Hepatology. 2009 May;49(5):1602-9. doi: 10.1002/hep.22843.

36.

Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.

Bauer S, Adrian N, Siebenborn U, Fadle N, Plesko M, Fischer E, Wüest T, Stenner F, Mertens JC, Knuth A, Ritter G, Old LJ, Renner C.

Cancer Immun. 2009 Mar 9;9:2.

37.

[A progressive ulcerative neck mass on the left infraauricular area].

Broglie MA, Tinguely M, Stenner F, Stöckli SJ.

HNO. 2008 Oct;56(10):1054-6. doi: 10.1007/s00106-008-1744-8. German. No abstract available.

PMID:
18836671
38.

Targeted therapeutic approach for an anaplastic thyroid cancer in vitro and in vivo.

Stenner F, Liewen H, Zweifel M, Weber A, Tchinda J, Bode B, Samaras P, Bauer S, Knuth A, Renner C.

Cancer Sci. 2008 Sep;99(9):1847-52. doi: 10.1111/j.1349-7006.2008.00882.x. Epub 2008 Jul 4.

39.

Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes.

Bauer S, Jendro MC, Wadle A, Kleber S, Stenner F, Dinser R, Reich A, Faccin E, Gödde S, Dinges H, Müller-Ladner U, Renner C.

Arthritis Res Ther. 2006;8(6):R171.

40.

Structure-activity profiles of Ab-derived TNF fusion proteins.

Bauer S, Adrian N, Fischer E, Kleber S, Stenner F, Wadle A, Fadle N, Zoellner A, Bernhardt R, Knuth A, Old LJ, Renner C.

J Immunol. 2006 Aug 15;177(4):2423-30.

41.

How useful is PET/CT imaging in the management of post-transplant lymphoproliferative disease after liver transplantation?

McCormack L, Hany TI, Hübner M, Petrowsky H, Mullhaupt B, Knuth A, Stenner F, Clavien PA.

Am J Transplant. 2006 Jul;6(7):1731-6.

42.

The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40.

Türeci O, Sahin U, Schobert I, Koslowski M, Scmitt H, Schild HJ, Stenner F, Seitz G, Rammensee HG, Pfreundschuh M.

Cancer Res. 1996 Oct 15;56(20):4766-72.

43.

Human neoplasms elicit multiple specific immune responses in the autologous host.

Sahin U, Türeci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M.

Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11810-3.

44.

Autonomic dysfunction in patients with achalasia.

Eckardt VF, Stenner F, Liewen H, Röder R, Koop H, Bernhard G.

Neurogastroenterol Motil. 1995 Mar;7(1):55-61.

PMID:
7627867

Supplemental Content

Loading ...
Support Center